Atlas Trials

A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Clinical trial NCT07313917 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07313917
Sponsor
Longbio Pharma
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Start date
2026-01-20
Primary completion
2027-02-28
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.